PolarCool meddelade idag den 26 september att bolaget har förlängt avtalet med HC Davos, vilket är e...
EcoRub genomför just nu bolagets företrädesemission där teckningstiden pågår fram tills den 11 oktob...
Redeye ups its near-term sales estimates for Ortoma following its USD8.
Redeye comments on W5’s announced acquisition of Box Modul which will add customized shelters to its...
Redeye considers the partnership with Elon Group AB (Elon) to be a strategically sound move that ali...
Biovica has signed its second direct commercial client bill agreement with a larger healthcare prov...
Redeye ser positivt på morgonens besked att Leqembi har godkänts i Japan och därmed att BioArctic få...
Redeye is favorable to the initiation of a new pilot with Bare Dermatology based in Texas.
I torsdags kväll lanserades Payday 3. Spelet nådde omkring 220 000 samtidiga spelare under lansering...
Redeye endorses yesterday’s news that Business Finland has waived-off around EUR4.
Movinn announced on September 21st, that the company launches a third Swedish market in the city of ...
Redeye provides a short comment regarding Hoylu’s recent announcement that the United States Navy ha...
Yesterday, Carasent announced that, following a review of the company’s capital structure, its board...
SSH Communications Security: Order announcement
As we had expected, Nanexa announced a SEK 121m rights issue, albeit at a slightly higher than expec...
Redeye comments on Nanexa’s rights issue that was announced earlier today.
Travere, with its conditionally approved FILSPARI, is the only Tarpeyo alternative for US patients.
Innehavet i Studentbostäder tyngde resultatet i Q2 och fokus framåt ligger på refinansiering av lån.
Redeye shares its takeaways from the Digitalize and Automate 2023 event – focusing on Effie AI and A...
Fas II-data från AKITA-studien Guard presenterade under tisdagen data från sin fas II-studie (AKITA)...
